Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Failure in pivotal PhIII brain cancer trial drags Israel’s VBL Therapeutics down
Failure in pivotal PhIII brain cancer trial drags Israel’s VBL Therapeutics down
Failure in pivotal PhIII brain cancer trial drags Israel’s VBL Therapeutics down
Submitted by
admin
on March 8, 2018 - 9:39am
Source:
Endpoints
News Tags:
clinical trials
VBL Therapeutics
VB-111
Roche
Avastin
glioblastoma
Headline:
Failure in pivotal PhIII brain cancer trial drags Israel’s VBL Therapeutics down
Do Not Allow Advertisers to Use My Personal information
